Subbu Nambi

Stock Analyst at Guggenheim

(0)
# 4334
Out of 5,328 analysts
36
Total ratings
26.92%
Success rate
-12.61%
Average return
20 Stocks
Name Action PT Current % Upside Ratings Updated
DHR Danaher
Reiterates: Buy
250 250
196.9 26.97% 1 Apr 23, 2025
CYRX CryoPort
Reiterates: Buy
10 10
5.45 83.49% 1 Apr 16, 2025
EXAS Exact Sciences
Reiterates: Buy
60 60
47.19 27.15% 2 Apr 11, 2025
NEOG Neogen
Maintains: Buy
15 13
5.13 153.41% 2 Apr 10, 2025
MYGN Myriad Genetics
Downgrades: Neutral
n/a
n/a n/a 2 Apr 9, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
45 37
29.7 24.58% 3 Apr 9, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
n/a
n/a n/a 2 Feb 25, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
n/a
n/a n/a 3 Feb 24, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
56 56
48.88 14.57% 5 Feb 24, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
170 150
76.54 95.98% 2 Feb 7, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
170 200
151.63 31.9% 2 Jan 17, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Neutral
n/a
n/a n/a 1 Oct 17, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
6
3.03 98.02% 1 Jun 27, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
6
0.69 769.57% 1 Jun 27, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 3 Jun 26, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Neutral
n/a
n/a n/a 1 Jun 18, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
53
37.83 40.1% 1 Jun 5, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
25
19.31 29.47% 1 Dec 14, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Neutral
n/a
n/a n/a 1 Dec 14, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Neutral
n/a
n/a n/a 1 Dec 14, 2023